Author

M. Selvaraju

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1 Research Focus:variant calling· 1 Organism:virus· 1

Frequent Co-Authors

J. Wang· 2 shared Z. Tang· 2 shared A. T. M. Saeb· 1 shared A. Zhen· 1 shared D. K. Johnson· 1 shared D. Sun· 1 shared H. T. Tayeb· 1 shared J. Qiu· 1 shared

Activity by Year

2016-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPharmacology & Toxicology

J. Wang

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Structural and Biological Evaluations of a Non-Nucleoside STING Agonist Specific for Human STINGA230 Variants

Z. Tang, J. Zhao, Y. Li, S. Tomer, M. Selvaraju, N. Tien, D. Sun, D. K. Johnson, A. Zhen, P. Li, J. Wang

The paper characterizes BDW568, a non-nucleoside STING agonist, showing it activates STINGA230 variants in human cells and mimics endogenous ligands.

bioRxiv · Jul 2, 2023 · PreprintPharmacology & Toxicology

Chemical-guided SHAPE sequencing (cgSHAPE-seq) informs the binding site of RNA-degrading chimeras targeting SARS-CoV-2 5' untranslated region

Z. Tang, S. Hegde, S. Hao, M. Selvaraju, J. Qiu, J. Wang

The paper develops cgSHAPE-seq to identify RNA-binding sites of coumarin derivatives targeting SARS-CoV-2 5' UTR and demonstrates their use as RNA-degrading chimeras to reduce viral RNA expression.

bioRxiv · Apr 3, 2023Biochemistry

Genome sequencing and analysis of the first spontaneous Nanosilver resistant bacterium Proteus mirabilis strain SCDR1

A. T. M. Saeb, K. Al-Rubeaan, M. Abouelhoda, M. Selvaraju, H. T. Tayeb

This study reports the genome sequencing and analysis of a novel Nanosilver-resistant Proteus mirabilis strain isolated from a diabetic ulcer patient, identifying resistance mechanisms and pathogenic potential.

bioRxiv · Nov 27, 2016Microbiology